Found 11 matching trials
A Study to Evaluate the Effects of Extended Release (ER) Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites in Subjects With High Cholesterol (0524A-075)(COMPLETED) PHASE1 The purpose of this study is to evaluate the potential effects of ER niacin...
Show More Location
Multiple Locations
Learn More & Join Trial
Carotid IMT (Intima Media Thickening) Study (0524A-041)(TERMINATED) PHASE3 This is a 105-week clinical study in patients with heterozygous familial hy...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED) PHASE1 This is a 3-period study. Periods 1 and 2 will evaluate the effects of mult...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Effects of ER Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites (0524A-079)(COMPLETED) PHASE1 The purpose of this study is to evaluate the potential effects of ER niacin...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of MK0524A on Cholesterol Levels (0524A-048) PHASE3 The primary objective of the study is to assess the effects of MK0524A in r...
Show More Location
Multiple Locations
Learn More & Join Trial
MK0524 Asthma POC Study (0524-008)(COMPLETED) PHASE2 The purpose of the study is to demonstrate the benefit of MK0524 compared t...
Show More Location
Multiple Locations
Learn More & Join Trial
Extended Niacin/Laropiprant in Patients With Type 2 Diabetes (0524A-069) PHASE3 A study to assess the efficacy and tolerability of ER (Extended Release) ni...
Show More Location
Multiple Locations
Learn More & Join Trial
MK0524A Clinical Efficacy Study (0524A-026)(COMPLETED) PHASE2 A study to determine lipid changing effects of MK0524A when compared to nia...
Show More Location
Multiple Locations
Learn More & Join Trial
An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia (0524A-032) PHASE2 This is a 3-week trial in normal healthy or lipid clinic patients studying ...
Show More Location
Multiple Locations
Learn More & Join Trial
MK0524A Phase IIb Study (0524A-011)(COMPLETED) PHASE2 Part A: This study will determine that MK0524 is well tolerated and does no...
Show More Location
Multiple Locations
Learn More & Join Trial